The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Anglo-Scandinavian Cardiac Outcomes Trial (Third Edition)

Anglo-Scandinavian Cardiac Outcomes Trial (Third Edition)

Neil R Poulter, Peter S Sever

ISBN: 978-1-905036-15-8


ASCOT is the largest study of hypertension ever undertaken in Europe involving >19,000 patients and also includes the study of lipid management in >10,000 patients. The results of ASCOT have had a significant impact on the prevention of coronary heart disease (CHD) and other vascular events by lowering blood pressure and reducing cholesterol. This further updated and expanded version provides clinicians with a comprehensive and detailed review of the final results of ASCOT by the steering committee of the trial. Additionally, the authors discuss implications of ASCOT for daily practice.

£14.99

Antithrombotic Therapy: New Drugs and Management Strategies

Antithrombotic Therapy: New Drugs and Management Strategies

FD Richard Hobbs, Gregory YH Lip

ISBN: 978-1-905036-16-5


All 'you need to know' about the fast-changing area of anticoagulation. What's the disease? Venous thromboembolisim explained Who is at risk? How can high risk patients be identified? What are the established treatments? What are the new novel anticoagulants? Similarities, differences and uses? What are the current guidelines? What are the implications for primary care?

£14.99

Visceral Obesity and Cardiometabolic Risk - A Handbook for Clinicians

Visceral Obesity and Cardiometabolic Risk - A Handbook for Clinicians

Jean-Pierre Despres

ISBN: 978-1905036080


In the coming decades, heart disease resulting from metabolic disorders will become the major cause of mortality and morbidity throughout the world. Cardiometabolic diseases such as dyslipidaemia, hypertension and diabetes are driving this so called "21st century epidemic". This handbook discusses the latest evidence linking visceral obesity with cardiometabolic disorders, providing easily accessible summaries of epidemiological and clinical data.

£14.99

Therapies for diabetes (including oral agents and insulins)

Therapies for diabetes (including oral agents and insulins)

Clifford Bailey, Michael D Feher

ISBN: 978-1905036004


A therapeutic guide developed to provide an attractive, readily accessible everyday reference source. Focussing on therapy of diabetes and covering the historical background of the drugs with their clinical pharmacology - notably mode of action, indications, efficacy, adverse effects, precautions, interactions and contraindications. This book will provide a convenient and enjoyable reference source with immediate information at your fingertips in a pocket-sized edition.

£14.99

High density cholesterol: the new target (Third edition)

High density cholesterol: the new target (Third edition)

Philip Barter, Kerry-Anne Rye

ISBN: 978-1-905036-10-3


Intervention trials using statins to lower LDL-C have consistently shown impressive reductions in major CV events. However, despite the effective lowering of LDL-C in these trials, there is an unacceptably high residual risk of having a major CV event. One reason for this relates to the presence of a low level of HDL-C. The combined results of population studies and clinical trials support the now accepted view that raising the level of HDL-C should be considered as a therapeutic target of importance comparable to that of lowering LDL-C. The time of HDL-C as a therapeutic target has arrived.

£14.99

Article search and filter